Performance
CJC-1295 No DAC
5 mg
GHRH analog (Mod GRF 1-29), studied for pulsatile GH release in preclinical models.
$69
Start OrderFor laboratory and research use only. Not for human or animal consumption.
Read the researchSpecifications
| Format | Lyophilized powder |
|---|---|
| Amount per vial | 5 mg |
| Presentation | Single-use sealed vial |
| Storage | Store lyophilized vial refrigerated or frozen; once reconstituted, keep refrigerated (2–8°C). |
| Purity | Third-party tested to 99%+. |
| Intended use | Laboratory and research use only. |
Areas of Research Interest
- Growth hormone optimization, CJC-1295 (no DAC) has been studied as a means to stimulate endogenous growth hormone production in research contexts
- Body composition modulation, Research has investigated potential effects on lean mass, fat distribution, and overall body composition metrics
- Recovery and repair, Studies have explored the peptide's potential relevance to tissue repair, angiogenesis, and recovery processes mediated by growth hormone
- Age-related GH decline, Research has examined CJC-1295 in models of age-related somatotropic axis decline
- Metabolic function, Studies have investigated effects on glucose homeostasis, lipid metabolism, and mitochondrial function
